M&G Investment Management’s Biogen BIIB Stock Holding History

M&G Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.23M	Hold	8,593	–	–	0.01%	309
2023 Q3	$2.21M	Hold	8,593	–	–	0.01%	313
2023 Q2	$2.45M	Sell	8,593 -387	-4%	-$115K	0.01%	309
2023 Q1	$2.5M	Sell	8,980 -3,863	-30%	-$1.07M	0.01%	281
2022 Q4	$3.56M	Hold	12,843	–	–	0.02%	242
2022 Q3	$3.43M	Sell	12,843 -156	-1%	-$33.1K	0.02%	242
2022 Q2	$2.65M	Hold	12,999	–	–	0.02%	276
2022 Q1	$2.74M	Hold	12,999	–	–	0.01%	280
2021 Q4	$3.12M	Sell	12,999 -73,893	-85%	-$19M	0.01%	275
2021 Q3	$24.6M	Buy	86,892 +27,777	+47%	+$9.1M	0.06%	185
2021 Q2	$20.5M	Buy	59,115 +41,364	+233%	+$12.5M	0.05%	189
2021 Q1	$4.97M	Sell	17,751 -4,711	-21%	-$1.27M	0.02%	238
2020 Q4	$5.5M	Sell	22,462 -8,500	-27%	-$2.19M	0.03%	224
2020 Q3	$8.79M	Sell	30,962 -1,440	-4%	-$402K	0.09%	175
2020 Q2	$8.68M	Buy	32,402 +13,249	+69%	+$3.98M	0.09%	174
2020 Q1	$6.05M	Sell	19,153 -35,290	-65%	-$10.7M	0.07%	180
2019 Q4	$16.2M	Buy	+54,443	New	+$15.1M	0.14%	137

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

M&G Investment Management's BIIB Position: Q4 2023 in Review

M&G Investment Management held its Biogen (BIIB) position steady in Q4 2023 at 8,593 shares worth $2.23M. The position accounts for 0.01% of the portfolio, ranked #309.

M&G Investment Management first reported a position in BIIB in Q4 2019 and has held it in 17 quarters since. The position peaked at $24.6M in Q3 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

M&G Investment Management held 8,593 shares of Biogen worth $2.23M as of Q4 2023.
M&G Investment Management left its Biogen share count unchanged in Q4 2023.
Biogen made up 0.01% of M&G Investment Management's portfolio in Q4 2023, its #309 holding.
M&G Investment Management first reported a position in Biogen in Q4 2019 and has held it in 17 quarters since.
M&G Investment Management's Biogen position peaked at $24.6M in Q3 2021.
1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.